|
|
|
|
|
 |
|
|
| |
 |
CME ACTIVITY |
 |
|
| Targeting the Pathophysiology of Type 2 Diabetes: The Emerging Role of Incretin-Based Therapies |
| Include proceedings from a symposium held during the 2008 Cardiometabolic Health Congress in Boston, Massachusetts |
Activity Date: December 2008
Activity Info: Volume 8, (11)
|
|
| |
|
|
|
|
Supported by an educational grant from |
| Novo Nordisk, Inc |
|
|
| |
|
|
|
|
|
|
|
|
|
|